Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?

• A. Employees' state Insurance Corporation
• B. CSIR-Central Drug Research Institute
• C. The Indian Council of Medical Research
• D. All India Institute Of Medical Science